9:30 am

For years, patient advocacy executives have been working to develop metrics to portray a tangible return on investment of their efforts and activities to senior management. From the hurdles of providingv ROI on relationship development to, showing concrete value in including the patient voice in the drug development process, there are a multitude of dimensions and aspects within their role, where proving ROI is starting to become more and more critical. Through this workshop, uncover multiple strategies to bring back to your team on developing tangible metrics and processes to bring to the table at your next senior management/ c-suite meeting.

CASE STUDY ONE: PHARMACEUTICAL ORGANIZATIONS TANGIBLE METRICS TO PROVE ROI

Melva Covington
Melva Covington
Senior Principal
AGAPE Strategic Solutions, LLC.

CASE STUDY TWO: PHARMACEUTICAL ORGANIZATIONS MOVING TOWARD PATIENT REPORTED OUTCOMES & ENDPOINTS

Karlin Schroeder
Karlin Schroeder, MA
Director, Community Engagement
Parkinson’s Foundation

1:30 pm

There will be a 15 minute break from 2:45 PM – 3:00 PM

PART ONE: ACCESS 101: REVIEW TOP INITIATIVES IN PATIENT ACCESS FROM THE STATE AND FEDERAL LEVEL

Brian Kennedy
Executive Director
Alliance for Patient Access

PART TWO: CASE STUDY: HOW TO ADDRESS ACCESS FROM THE STATE AND FEDERAL LEVEL TO ENSURE PATIENTS HAVE QUALTY ACCESS TO CARE

Scott Bruun
Scott Bruun
Executive Director
Chronic Disease Coalition